GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Biotech Growth Trust (The) PLC (LSE:BIOG) » Definitions » Equity-to-Asset

Biotech Growth Trust (The) (LSE:BIOG) Equity-to-Asset : 0.95 (As of Sep. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Biotech Growth Trust (The) Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Biotech Growth Trust (The)'s Total Stockholders Equity for the quarter that ended in Sep. 2023 was £293.42 Mil. Biotech Growth Trust (The)'s Total Assets for the quarter that ended in Sep. 2023 was £308.21 Mil. Therefore, Biotech Growth Trust (The)'s Equity to Asset Ratio for the quarter that ended in Sep. 2023 was 0.95.

The historical rank and industry rank for Biotech Growth Trust (The)'s Equity-to-Asset or its related term are showing as below:

LSE:BIOG' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.85   Med: 0.92   Max: 0.97
Current: 0.95

During the past 13 years, the highest Equity to Asset Ratio of Biotech Growth Trust (The) was 0.97. The lowest was 0.85. And the median was 0.92.

LSE:BIOG's Equity-to-Asset is ranked better than
72.03% of 1727 companies
in the Asset Management industry
Industry Median: 0.82 vs LSE:BIOG: 0.95

Biotech Growth Trust (The) Equity-to-Asset Historical Data

The historical data trend for Biotech Growth Trust (The)'s Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotech Growth Trust (The) Equity-to-Asset Chart

Biotech Growth Trust (The) Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.95 0.91 0.93 0.92 0.92

Biotech Growth Trust (The) Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.95 0.92 0.94 0.92 0.95

Competitive Comparison of Biotech Growth Trust (The)'s Equity-to-Asset

For the Asset Management subindustry, Biotech Growth Trust (The)'s Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotech Growth Trust (The)'s Equity-to-Asset Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Biotech Growth Trust (The)'s Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Biotech Growth Trust (The)'s Equity-to-Asset falls into.



Biotech Growth Trust (The) Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Biotech Growth Trust (The)'s Equity to Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Equity to Asset (A: Mar. 2023 )=Total Stockholders Equity/Total Assets
=330.291/360.509
=0.92

Biotech Growth Trust (The)'s Equity to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

Equity to Asset (Q: Sep. 2023 )=Total Stockholders Equity/Total Assets
=293.417/308.211
=0.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biotech Growth Trust (The)  (LSE:BIOG) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Biotech Growth Trust (The) Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Biotech Growth Trust (The)'s Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotech Growth Trust (The) (LSE:BIOG) Business Description

Traded in Other Exchanges
Address
25 Southampton Buildings, London, GBR, WC2A 1AL
Biotech Growth Trust (The) PLC is a United Kingdom-based investment trust. Its business objective is to provide its investors with capital appreciation by investing in the biotechnology industry around the world. The company portfolio comprises emerging biotechnology companies across North America, Europe, and Asia, of which North America accounts for the investment share.

Biotech Growth Trust (The) (LSE:BIOG) Headlines

No Headlines